Article

Identification of biomarkers and pathways to identify novel therapeutic targets in Alzheimer’s disease: Insights from a systems biomedicine perspective

2018-11-29

Abstract excerpt

Alzheimer’s disease (AD) is a progressive neurodegenerative disease characterized by the accumulation of amyloid plaques and neurofibrillary tangles in the brain. However, there are no peripheral biomarkers available that can detect AD onset. This study aimed to identify such AD biomarkers through an integrative analysis of blood cell gene expression data. We used two microarray datasets (GSE4226 and GSE4229) comp...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 2d8e609d-877c-57a8-9700-69fc115cc503
DOI: 10.1101/481879

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Identification of biomarkers and pathways to identify novel therapeutic targets in Alzheimer’s disease: Insights from a systems biomedicine perspectiveDOI 10.1101/481879Read

Identification of molecular signatures and pathways to identify novel therapeutic targets in Alzheimer's disease: Insights from a systems biomedicine perspectiveSemantic proximity Read

Screening and Identification of Potential Peripheral Blood Biomarkers for Alzheimer’s Disease Based on Bioinformatics AnalysisSemantic proximity Read

Identification of dysregulated genes and pathways of different brain regions in Alzheimer’s diseaseSemantic proximity Read

Integrated Bioinformatics and Ensemble Learning Reveal Diagnostic Modeling and Drug Discovery in Alzheimer’s DiseaseSemantic proximity Read

Detection of molecular signatures and pathways shared by Alzheimer’s disease and type 2 diabetesSemantic proximity Read

Identification of Common Molecular Signatures Shared between Alzheimer’s and Parkinson’s Diseases and Therapeutic Agents Exploration: An Integrated Genomics ApproachSemantic proximity Read

Identification of common molecular biomarker signatures in blood and brain of Alzheimer’s diseaseSemantic proximity Read

Identification and validation of oxidative stress and immune-related hub genes in Alzheimer’s disease through bioinformatics analysisSemantic proximity Read

Exploring the Key Genes and Identification of Potential Diagnosis Biomarkers in Alzheimer’s Disease Using Bioinformatics AnalysisSemantic proximity Read

Identification of candidate biomarkers and signaling pathways associated with Alzheimer’s disease using bioinformatics analysis of next generation sequencing dataSemantic proximity Read

Identification of oxidative stress-related genes differentially expressed in Alzheimer’s disease and construction of a hub gene-based diagnostic modelSemantic proximity Read

Microarray Analysis of Differential Gene Expression in Alzheimer’s Disease Identifies Potential Biomarkers with Diagnostic ValueSemantic proximity Read